Clinical pathways in oncology have the potential to enhance cancer care by lowering costs while preserving quality. Cigna and eviCore Healthcare collaborated to create the Oncology Value-based paths program, which includes 51 therapeutic paths for treating 50% of malignancies. They wanted to give advice to physicians while also ensuring that patients received cheap treatment. In January 2021, the program was introduced for a big commercial population. The route regimen rate increased by 5.2% during an 18-month period, saving $24 million. Direct talks with clinicians who ordered off-pathway therapies resulted in 18.3% of cases being updated to on-pathway regimens. Overall, 28.3% of patients were finally switched to on-pathway regimens, indicating that the initiative had a broader educational impact than merely provider talks.

To know more: About the original article click here.